Upgrade to SI Premium - Free Trial

Lixte Biotechnology Holdings, Inc. (LIXT)

7.00 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/7/25 *Est.)

Latest Headlines

Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Jun 02 June 4, 2026 5:01 PM - SEC Filing Form 424B5 LIXTE BIOTECHNOLOGY HOLD June 4, 2026 4:41 PM - SEC Filing LIXTE Biotechnology raises $16.6 million through registered direct offering June 3, 2026 8:30 AM - StreetInsider LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth June 3, 2026 8:30 AM - StreetInsider Form 4 LIXTE BIOTECHNOLOGY HOLD For: May 29 Filed by: Porter Stuart D June 1, 2026 4:01 PM - SEC Filing Form 3 LIXTE BIOTECHNOLOGY HOLD For: May 29 Filed by: Porter Stuart D June 1, 2026 4:00 PM - SEC Filing Form 8-K LIXTE BIOTECHNOLOGY HOLD For: May 29 June 1, 2026 8:55 AM - SEC Filing LIXTE Biotechnology pivots to AI energy infrastructure services June 1, 2026 8:50 AM - StreetInsider LIXTE Biotechnology pivots to AI energy infrastructure business June 1, 2026 8:50 AM - StreetInsider LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors June 1, 2026 8:50 AM - Globe NewsWire LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors June 1, 2026 8:50 AM - StreetInsider LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update May 14, 2026 5:18 PM - Globe NewsWire Form 10-Q LIXTE BIOTECHNOLOGY HOLD For: Mar 31 May 14, 2026 4:51 PM - SEC Filing Form 4 LIXTE BIOTECHNOLOGY HOLD For: Apr 15 Filed by: Felix Lourdes April 17, 2026 4:16 PM - SEC Filing Form 4 LIXTE BIOTECHNOLOGY HOLD For: Apr 15 Filed by: Pursglove Geordan Garrett April 17, 2026 4:16 PM - SEC Filing Form 4 LIXTE BIOTECHNOLOGY HOLD For: Apr 15 Filed by: Stazzone Peter April 17, 2026 4:16 PM - SEC Filing Form 4 LIXTE BIOTECHNOLOGY HOLD For: Apr 15 Filed by: Holloway Michael Andrew April 17, 2026 4:16 PM - SEC Filing Form 4 LIXTE BIOTECHNOLOGY HOLD For: Apr 15 Filed by: Sawyer Jason David April 17, 2026 4:16 PM - SEC Filing Form 4 LIXTE BIOTECHNOLOGY HOLD For: Apr 15 Filed by: Primus Guy Warren April 17, 2026 4:16 PM - SEC Filing Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Apr 15 April 17, 2026 4:06 PM - SEC Filing Favorable Results of Ovarian Cancer Study Presented at Annual Society of Gynecological Care Conference April 13, 2026 8:00 AM - Globe NewsWire LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year March 31, 2026 3:45 PM - StreetInsider Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31 March 31, 2026 3:13 PM - SEC Filing Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Mar 18 March 20, 2026 4:05 PM - SEC Filing Form 8-K LIXTE BIOTECHNOLOGY HOLD For: Mar 06 March 10, 2026 4:01 PM - SEC Filing Full Article List